BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 16796791)

  • 1. Targeted agents for adjuvant therapy of colon cancer.
    Saif MW
    Clin Colorectal Cancer; 2006 May; 6(1):46-51. PubMed ID: 16796791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Adjuvant and palliative anticancer treatment of colon carcinoma in 2004].
    Medinger M; Steinbild S; Mross K
    Praxis (Bern 1994); 2004 Sep; 93(40):1633-44. PubMed ID: 15495753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted therapy in colorectal cancer.
    Rajpal S; Venook AP
    Clin Adv Hematol Oncol; 2006 Feb; 4(2):124-32. PubMed ID: 16728921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The future development of bevacizumab in colorectal cancer.
    Díaz-Rubio E; Schmoll HJ
    Oncology; 2005; 69 Suppl 3():34-45. PubMed ID: 16301834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Why do targeted agents not work in the adjuvant setting in colon cancer?
    Oyan B
    Expert Rev Anticancer Ther; 2012 Oct; 12(10):1337-45. PubMed ID: 23176621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted drugs in metastatic colorectal cancer with special emphasis on guidelines for the use of bevacizumab and cetuximab: an Acta Oncologica expert report.
    Nygren P; Sørbye H; Osterlund P; Pfeiffer P
    Acta Oncol; 2005; 44(3):203-17. PubMed ID: 16076691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy of metastatic colorectal cancer.
    Prescrire Int; 2010 Oct; 19(109):219-24. PubMed ID: 21180382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiangiogenesis agents in colorectal cancer.
    Hubbard J; Grothey A
    Curr Opin Oncol; 2010 Jul; 22(4):374-80. PubMed ID: 20375894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bevacizumab: an angiogenesis inhibitor for the treatment of solid malignancies.
    Shih T; Lindley C
    Clin Ther; 2006 Nov; 28(11):1779-802. PubMed ID: 17212999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver resection for metastatic colorectal cancer in the age of neoadjuvant chemotherapy and bevacizumab.
    Yoo PS; Lopez-Soler RI; Longo WE; Cha CH
    Clin Colorectal Cancer; 2006 Sep; 6(3):202-7. PubMed ID: 17026789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant therapy of colon cancer: current status and future directions.
    Chung KY; Saltz LB
    Cancer J; 2007; 13(3):192-7. PubMed ID: 17620769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Colon cancer: what is new in 2004?].
    André T; Louvet C; de Gramont A
    Bull Cancer; 2004 Jan; 91(1):75-80. PubMed ID: 14975808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant treatment of colon cancer: what is next?
    Van Loon K; Venook AP
    Curr Opin Oncol; 2011 Jul; 23(4):403-9. PubMed ID: 21537178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bevacizumab in the treatment of metastatic colorectal cancer (mCRC) in second- and third-line settings.
    Giantonio BJ
    Semin Oncol; 2006 Oct; 33(5 Suppl 10):S15-8. PubMed ID: 17145520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anti-angiogenic treatment and colorectal cancer].
    André T; Tournigand C; Abbas F; Louvet C; de Gramont A;
    Bull Cancer; 2007 Jul; 94 Spec No():S211-9. PubMed ID: 17846007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted agents to improve treatment results in colon cancer: bevacizumab and cetuximab.
    Klein B; Gottfried M
    J BUON; 2007 Sep; 12 Suppl 1():S127-36. PubMed ID: 17935270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stage II and stage III colon cancer: treatment advances and future directions.
    Rousseau B; Chibaudel B; Bachet JB; Larsen AK; Tournigand C; Louvet C; André T; de Gramont A;
    Cancer J; 2010; 16(3):202-9. PubMed ID: 20526097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Multimodal therapy for colon cancer: state of the art].
    Weber T; Link KH
    Zentralbl Chir; 2011 Aug; 136(4):325-33. PubMed ID: 21863510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cetuximab plus oxaliplatin-based chemotherapy in the treatment of colorectal cancer.
    Moosmann N; Heinemann V
    Expert Rev Anticancer Ther; 2008 Mar; 8(3):319-29. PubMed ID: 18366281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress and challenges in the adjuvant treatment of stage II and III colon cancers.
    Chua YJ; Zalcberg JR
    Expert Rev Anticancer Ther; 2008 Apr; 8(4):595-604. PubMed ID: 18402526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.